- Acquired by OPKO Health Inc. for $27.5M, Feb 2012
About
FineTech Pharmaceutical Ltd. focuses on the development and production of low volume, high value specialty Active Pharmaceutical Ingredients (APIs). The company develops "by-passes" to process and polymorph patents by creating non-infringing processes or polymorphs that can be patented independently. They offer a full range of services from paper chemistry to laboratory scale development, pilot scale, and commercial production. FineTech also provides analytical method development, regulatory affairs, and complete literature and patent analysis. The company is staffed with highly qualified scientists experienced in synthetic and analytical chemistry, with expertise in multi-step synthesis, new polymorph development, chiral, and prostaglandin chemistry. Their FDA registered facility operates on a 6-building campus equipped with state-of-the-art laboratory, production, and quality control equipment. FineTech's business model has been to develop complex and problematic APIs for sale or license to pharmaceutical companies in the United States, Canada, Europe, and Israel.
Q&A
- What is FineTech Pharmaceutical's primary business?
- FineTech Pharmaceutical develops and manufactures active pharmaceutical ingredients (APIs) with the goal of bypassing process and polymorph patents. The company also offers analytical method development and patent analysis.
- When was FineTech Pharmaceutical founded?
- FineTech Pharmaceutical was founded in January 1990 as FineTech Laboratories Ltd in conjunction with the Technion – Israel Institute of Technology.
- What is the current status of FineTech Pharmaceutical?
- FineTech Pharmaceutical was acquired by OPKO Health in December 2011.
- What types of APIs does FineTech Pharmaceutical specialize in?
- FineTech Pharmaceutical's APIs include Cabergoline, Latanoprost, Travoprost, Bimatoprost, Nabilone, donepezil hydrochloride, aminolevulinic acid hydrochloride, melatonin, and methylbenzethonium chloride. The company specializes in organic processes, including multi-step synthesis, polymorph development, chromatography, and chiral and prostaglandin chemistry.
- How many employees does FineTech Pharmaceutical have?
- FineTech Pharmaceutical has an employee count in the 11-50 range.
- Where is FineTech Pharmaceutical headquartered?
- FineTech Pharmaceutical is headquartered in Nesher, North District, Israel.
- What certifications or standards does FineTech Pharmaceutical adhere to?
- FineTech Pharmaceutical operates in an FDA-registered facility and abides by cGMP standards.
- Does FineTech Pharmaceutical hold any patents?
- Yes, FineTech Pharmaceutical has patents.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | finetechlab.com |
|---|
Identifiers & details
| Legal name | FineTech Pharmaceutical, Ltd. |
|---|---|
| Founded | 1990 |
| Employees (exact) | 31 |
| Status reason | Acquired by OPKO Health on Dec, 2011 |
Acquisitions & public offerings
Acquired by OPKO Health Inc. 2012-02 $27.5M
Radar intelligence
Patents
| EPO | 6 |
|---|
Web history (Wayback)
| Domain | finetechlab.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514072271 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2008-01-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 1 — annual_report (1) |
| Registered address | נרקיסים 33 נשר |
Recent registry events
| Date | Event |
|---|---|
| 2026-02-01 | דו~ח שנתי |